Who is suitable for IVF in Thailand? In-depth analysis of medical indications, suitable populations, and contraindications
Opening: Doctor's decision-making logic (real consultation scenario)
In a reproductive clinic, a 42-year-old woman with an AMH level of 0.8 ng/mL asks, "Doctor, is it suitable for me to do IVF in Thailand?" This is not an isolated case. Every week, we encounter similar consultations: patients who are older, have declining ovarian function, have experienced failed transfers domestically, or have genetic disease needs, considering whether to go to Thailand for IVF. Answering this question cannot be a simple "yes" or "no"; it requires a comprehensive assessment based on multiple dimensions including medical indications, age, physical condition, and previous treatment history.
1. Who is suitable for IVF in Thailand: An analysis guided by medical indications
IVF-ET technology in Thailand has specific applicable populations in the field of assisted reproduction. From a medical perspective, the following groups are the main candidates for IVF in Thailand.
1. Advanced Maternal Age and Diminished Ovarian Reserve
Women over 38 years old with AMH below 1.2 ng/mL, FSH above 10 IU/L, and an antral follicle count (AFC) of less than 6 are considered to have diminished ovarian reserve (DOR). An FSH/LH ratio >2 also indicates decreased ovarian reserve. These patients may have fewer retrieved eggs and poorer embryo quality during ovarian stimulation in China. Some reproductive centers in Thailand offer more flexible stimulation protocols, such as the PPOS protocol or mild stimulation, which can be advantageous for patients with diminished ovarian reserve.
2. Tubal Factor Infertility
Bilateral tubal blockage, severe hydrosalpinx, or post-salpingectomy interrupts the natural conception pathway. IVF is the only option. Technologically, there is little difference between Thailand and China, but if the patient has other concurrent factors (e.g., advanced age, declining ovarian function), Thailand may have more experience in comprehensive management.
3. Moderate to Severe Male Oligoasthenoteratozoospermia
Sperm concentration below 5×10⁶/mL, or motility below 10%, or sperm morphology below 98% normal forms constitutes moderate to severe oligoasthenoteratozoospermia. Some laboratories in Thailand have extensive experience in sperm processing techniques and ICSI (Intracytoplasmic Sperm Injection) procedures, especially for sperm selection in cases of extremely severe oligoasthenoteratozoospermia.
4. Carriers of Genetic Diseases Requiring PGT Screening
Couples where one or both partners are carriers of monogenic diseases (e.g., thalassemia, spinal muscular atrophy) or have chromosomal structural abnormalities (e.g., reciprocal translocation, Robertsonian translocation) require preimplantation genetic testing (PGT). Thailand has an earlier start in the application of PGT technology, relatively rich experience, and the cost of PGT is lower than in European and American countries.
5. Recurrent Implantation Failure
Experiencing 2 or more implantation failures after transferring good-quality embryos. Causes may include poor endometrial receptivity, embryonic chromosomal abnormalities, immune factors, etc. Some hospitals in Thailand can perform ERA (Endometrial Receptivity Analysis) and endometrial microbiome testing to help identify the cause.
6. Unexplained Infertility
Couples with no clear abnormalities found in routine examinations but who have not conceived after more than one year. If 2-3 cycles of ovulation induction or intrauterine insemination (IUI) in China have not resulted in pregnancy, IVF can be considered. IVF in Thailand differs in protocol selection from China, but it is not the first choice.
2. Differences in suitability and success rate considerations by age group
Age is a core factor affecting IVF success rates. Suitability and expected success rates for IVF in Thailand vary significantly across different age groups.
| Age Group | Ovarian Function Characteristics | Suitability Assessment for IVF Thailand | Expected Live Birth Rate (Per Cycle) |
|---|---|---|---|
| ≤35 years | Normal function | Unless there are genetic diseases or multiple failures, domestic treatment is sufficient. | 40%–50% |
| 36–37 years | Function begins to decline | Can be considered if other combined factors exist. | 30%–40% |
| 38–40 years | Function significantly declines | Thailand offers flexible stimulation protocols, suitable for DOR patients. | 20%–30% |
| 41–42 years | Function severely declines | Strict evaluation of follicle quantity and quality required. | 10%–15% |
| ≥43 years | Ovarian failure phase | Success rate is extremely low; thorough communication is needed. | <5% |
From the data, women over 38 are more likely to benefit from IVF in Thailand, provided there are still usable follicles in the ovaries. For patients over 43, success rates drop significantly both in Thailand and domestically, requiring very cautious decision-making.
3. Differences between assisted reproduction in Thailand and China: How to choose
Patients often ask, "What makes IVF in Thailand better than in China?" This is not a black-and-white issue.
Main characteristics of IVF in Thailand
- Wider application of PGT technology, with more experience in genetic disease screening and chromosomal screening.
- More flexible choice of stimulation protocols, with more protocol options for older patients and those with diminished ovarian reserve (e.g., PPOS, mild stimulation, natural cycle).
- Laboratory culture systems aligned with European/American standards, with some centers showing stable performance in embryo culture and cryopreservation.
- Higher acceptance of older patients, whereas some domestic centers have limited recommendations for patients over 42.
Main characteristics of IVF in China
- Lower communication costs for consultations, with no language barriers.
- Relatively lower costs, approximately 30,000–50,000 RMB per cycle.
- Gradual inclusion in medical insurance policies, with some examination items reimbursable.
- No need for visas, translation, accommodation, and other additional arrangements.
Core logic for choosing IVF in Thailand: When domestic treatment encounters a bottleneck (e.g., failed stimulation due to poor ovarian function, recurrent implantation failure, need for PGT screening), and the patient's physical and financial conditions allow, Thailand can be considered as an alternative. However, it is not recommended to blindly choose Thailand without a thorough evaluation.
4. The most easily overlooked evaluation details
Several details are easily overlooked when determining suitability for IVF in Thailand:
- Timing of AMH testing: AMH should be tested via blood draw during menstruation, and no hormonal medications should have been taken in the month prior to testing. AMH levels reflect ovarian reserve but do not represent egg quality.
- Chromosomal testing for both partners: Both partners need peripheral blood karyotype analysis. Some carriers of genetic diseases are asymptomatic but may affect the embryo.
- Hysteroscopy: Ultrasound cannot detect all uterine cavity issues. Hysteroscopy is the gold standard for assessing endometrial receptivity. Intrauterine adhesions, endometrial polyps, chronic endometritis, etc., can all affect implantation.
- Male semen analysis: Semen analysis should be performed 3-7 days after ejaculation, and at least twice. A single abnormal result requires repeat testing for confirmation.
- Passport and visa: Passport validity must be more than 6 months. IVF in Thailand requires notarization and translation of the marriage certificate, which some hospitals may request.
- Pre-treatment preparation: In the 3 months before starting the cycle, it is recommended to supplement with Coenzyme Q10, Vitamin D, folic acid, etc. Men should supplement with zinc and selenium. This is not superstition but known factors affecting gamete quality.
5. Who is not suitable for IVF in Thailand
Not everyone is suitable for IVF in Thailand. Doctors generally do not recommend it in the following situations:
| Situation | Specific Criteria | Why Not Recommended |
|---|---|---|
| Complete Ovarian Failure | FSH >40 IU/L, AMH <0.01 ng/mL, no antral follicles visible on ultrasound | The chance of retrieving eggs is extremely low regardless of location. Egg donation should be considered. |
| Severe Endometrial Damage | Asherman's syndrome (severe intrauterine adhesions) unimproved after surgical repair, or persistently thin endometrium <5mm | Embryos cannot implant, leading to wasted transfer cycles. |
| Uncontrolled Severe Medical or Surgical Conditions | Blood pressure >160/100 mmHg, HbA1c >8%, TSH >4.0 mIU/L | Increases risks during stimulation and pregnancy; the condition must be stabilized first. |
| Severe Mental Illness | Uncontrolled depression, anxiety disorder, schizophrenia, etc. | The treatment process is stressful and may trigger or worsen the condition. |
| Legally Prohibited Requests | Non-medical sex selection, commercial surrogacy | Prohibited by Thai law, unprotected, and carries ethical risks. |
6. Frequently Asked Questions
7. Doctor's Advice
IVF in Thailand is an option, but not a universal solution. Suitability depends on specific medical indications, age, physical condition, and financial status. It is recommended to first complete a systematic fertility evaluation in China, including AMH, FSH, LH, antral follicle count, semen analysis, chromosomal testing, and uterine cavity assessment. Only with a complete set of reports should you discuss with a reproductive specialist whether going to Thailand is necessary.
If you have already decided to go, you must also plan your time, prepare documents, and budget financially. Most importantly, manage your expectations—IVF in Thailand is not a miracle machine; its success rates, like those in China, are strictly constrained by age and physical condition.
Ending: Risk Reminder
Risk Reminder: All assisted reproductive treatments carry medical risks, including but not limited to OHSS, complications from egg retrieval, embryo developmental arrest, and implantation failure. There is no essential difference in medical risks between Thailand and China. Before choosing overseas medical treatment, it is advisable to fully understand the local medical regulations, institutional qualifications, and dispute resolution mechanisms. The content of this article is for medical knowledge reference only and does not constitute medical advice. Please consult a licensed reproductive physician for specific treatment plans.
